Wendy K Chung
Biographic Data
| ID | 5506036 |
|---|---|
| NAME | Wendy K Chung |
| GIVEN NAMES | Wendy K |
| FAMILY NAME | Chung |
| SIGNATURE | CHUNG W K |
| VERIFIED | No |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 6 |
| AUTHOR COUNT | 5 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2014 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 1 |
Understanding individualised genetic interventions as research-treatment hybrids
Until recently, medicine has had little to offer most of the millions of patients suffering from rare and ultrarare genetic conditions. But the development in 2019 of Milasen, the first genetic intervention developed for and administered to a single patient suffering from an ultrarare genetic disorder, has offered hope to patients and families. In addition, Milasen raised a series of conceptual and ethical questions about how individualised genet…
Choices, attitudes, and experiences of genetic screening in Latino/a and Ashkenazi Jewish individuals
Assessing patient readiness for personalized genomic medicine
Models of Consent to Return of Incidental Findings in Genomic Research
Genomic research-including whole genome sequencing and whole exome sequencing-has a growing presence in contemporary biomedical investigation. The capacity of sequencing techniques to generate results that go beyond the primary aims of the research-historically referred to as "incidental findings"-has generated considerable discussion as to how this information should be handled-that is, whether incidental results should be returned, and if so, w…
Bitter taste phenotype and body weight predict children's selection of sweet and savory foods at a palatable test-meal
Models of Consent to Return of Incidental Findings in Genomic Research
Genomic research-including whole genome sequencing and whole exome sequencing-has a growing presence in contemporary biomedical investigation. The capacity of sequencing techniques to generate results that go beyond the primary aims of the research-historically referred to as "incidental findings"-has generated considerable discussion as to how this information should be handled-that is, whether incidental results should be returned, and if so, w…
Bitter taste phenotype and body weight predict children's selection of sweet and savory foods at a palatable test-meal
Assessing patient readiness for personalized genomic medicine
Choices, attitudes, and experiences of genetic screening in Latino/a and Ashkenazi Jewish individuals
Understanding individualised genetic interventions as research-treatment hybrids
Until recently, medicine has had little to offer most of the millions of patients suffering from rare and ultrarare genetic conditions. But the development in 2019 of Milasen, the first genetic intervention developed for and administered to a single patient suffering from an ultrarare genetic disorder, has offered hope to patients and families. In addition, Milasen raised a series of conceptual and ethical questions about how individualised genet…
Biology (4 works) · Genomics and Rare Diseases (4 works) · Medicine (4 works) · Ethics in Clinical Research (3 works) · Genetic testing (3 works) · Bioinformatics (2 works) · BRCA gene mutations in cancer (2 works) · Computer Science (2 works) · Confidentiality (2 works) · Family medicine (2 works)